PARP 抑制对软骨肉瘤和软骨细胞的放射增敏作用依赖于射线的线性能量传递。
Radiosensitizing Effect of PARP Inhibition on Chondrosarcoma and Chondrocyte Cells Is Dependent on Radiation LET.
机构信息
UMR6252 CIMAP, CEA-CNRS-ENSICAEN, Normandie Université, Team Applications in Radiobiology with Accelerated Ions, 14000 Caen, France.
Department of Life and Environmental Physics, Horia Hulubei National Institute for R&D in Physics and Nuclear Engineering, Reactorului 30, 077125 Magurele, Romania.
出版信息
Biomolecules. 2024 Aug 27;14(9):1071. doi: 10.3390/biom14091071.
Chondrosarcoma is a rare malignant tumor that forms in bone and cartilage. The primary treatment involves surgical removal of the tumor with a margin of healthy tissue. Especially if complete surgical removal is not possible, radiation therapy and chemotherapy are used in conjunction with surgery, but with a generally low efficiency. Ongoing researches are focused on understanding the genetic and molecular basis of chondrosarcoma following high linear energy transfer (LET) irradiation, which may lead to treatments that are more effective. The goal of this study is to evaluate the differential effects of DNA damage repair inhibitors and high LET irradiation on chondrosarcoma versus chondrocyte cells and the LET-dependency of the effects. Two chondrosarcoma cell lines with different mutation status and one chondrocyte cell line were exposed to low LET (X-ray) and high LET (carbon ion) irradiation in combination with an Olaparib PARP inhibitor. Cell survival and DNA repair mechanisms were investigated. High LET irradiation drastically reduced cell survival, with a biological efficiency three times that of low LET. Olaparib significantly inhibited PARylation in all the tested cells. A significant reduction in cell survival of both chondrosarcoma and chondrocyte cells was observed following the treatment combining Olaparib and X-ray. PARP inhibition induced an increase in PARP-1 expression and a reduced effect on the cell survival of WT chondrosarcoma cells. No radiosensitizing effect was observed in cells exposed to Olaparib paired with high LET irradiation. NHEJ was activated in response to high LET irradiation, neutralizing the PARP inhibition effect in both chondrosarcoma cell lines. When high LET irradiation is not available, PARP inhibition could be used in combination with low LET irradiation, with significant radiosensitizing effects on chondrosarcoma cells. Chondrocytes may be affected by the treatment combination too, showing the need to preserve normal tissues from radiation fields when this kind of treatment is suggested.
软骨肉瘤是一种罕见的恶性肿瘤,形成于骨骼和软骨中。主要的治疗方法是通过手术切除肿瘤并保留健康组织。特别是如果不能完全切除肿瘤,通常会结合手术使用放射治疗和化学疗法,但效率普遍较低。目前的研究集中于了解高线性能量转移(LET)照射后软骨肉瘤的遗传和分子基础,这可能会导致更有效的治疗方法。本研究的目的是评估 DNA 损伤修复抑制剂和高 LET 照射对软骨肉瘤与软骨细胞的差异影响,以及这些影响对 LET 的依赖性。用低 LET(X 射线)和高 LET(碳离子)照射两种具有不同 突变状态的软骨肉瘤细胞系和一种软骨细胞系,并与奥拉帕利(Olaparib)PARP 抑制剂联合使用。研究了细胞存活和 DNA 修复机制。高 LET 照射可大大降低细胞存活率,其生物效率是低 LET 的三倍。奥拉帕利在所有测试的细胞中均显著抑制 PAR 化。在奥拉帕利联合 X 射线治疗后,观察到两种软骨肉瘤和软骨细胞的存活率明显降低。PARP 抑制会导致 PARP-1 表达增加,并降低 WT 软骨肉瘤细胞的存活率。在暴露于奥拉帕利联合高 LET 照射的细胞中未观察到放射增敏作用。NHEJ 被高 LET 照射激活,中和了两种软骨肉瘤细胞系中 PARP 抑制的作用。当无法进行高 LET 照射时,PARP 抑制可与低 LET 照射联合使用,对软骨肉瘤细胞具有显著的放射增敏作用。软骨细胞也可能受到治疗联合的影响,这表明在建议这种治疗方法时,需要保护正常组织免受辐射场的影响。